Mustafa Shadi Rifaat Bashir, MD

Associate Professor of Radiology
Associate Professor in the Department of Medicine
Member of the Duke Cancer Institute
Campus mail Dept of Radiology, Box 3808, Durham, NC 27710
Phone (919) 684-7366
Email address mustafa.bashir@duke.edu

Hepatobiliary and pancreatic imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging

Education and Training

  • M.D., University of Iowa, 2004

Publications

Nouls, John C., Rohan S. Virgincar, Alexander G. Culbert, Nathann Morand, Dana W. Bobbert, Anne D. Yoder, Robert S. Schopler, et al. “Applications of 3D printing in small animal magnetic resonance imaging..” J Med Imaging (Bellingham) 6, no. 2 (April 2019). https://doi.org/10.1117/1.JMI.6.2.021605.

PMID
31131288
Full Text

Kielar, Ania Z., Victoria Chernyak, Mustafa R. Bashir, Richard K. Do, Kathryn J. Fowler, Cynthia Santillan, Claude B. Sirlin, et al. “An update for LI-RADS: Version 2018. Why so soon after version 2017?.” J Magn Reson Imaging, March 12, 2019. https://doi.org/10.1002/jmri.26715.

PMID
30864185
Full Text

Pol, Christian B. van der, Christopher S. Lim, Claude B. Sirlin, Trevor A. McGrath, Jean-Paul Salameh, Mustafa R. Bashir, An Tang, et al. “Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review..” Gastroenterology 156, no. 4 (March 2019): 976–86. https://doi.org/10.1053/j.gastro.2018.11.020.

PMID
30445016
Full Text

Ehieli, Wendy L., Erol Bozdogan, Gemini Janas, Tracy A. Jaffe, Chad M. Miller, Mustafa R. Bashir, and Brian C. Allen. “Imaging-guided percutaneous thrombin injection for the treatment of iatrogenic femoral artery pseudoaneurysms..” Abdom Radiol (Ny) 44, no. 3 (March 2019): 1120–26. https://doi.org/10.1007/s00261-019-01923-6.

PMID
30739134
Full Text

Harrison, Stephen A., Stephen J. Rossi, Angelo H. Paredes, James F. Trotter, Mustafa R. Bashir, Cynthia D. Guy, Rajarshi Banerjee, et al. “NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis..” Hepatology, February 25, 2019. https://doi.org/10.1002/hep.30590.

PMID
30805949
Full Text

Bashir, Mustafa R., and Victoria Chernyak. “Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?.” Radiology 290, no. 2 (February 2019): 398–99. https://doi.org/10.1148/radiol.2018182408.

PMID
30422087
Full Text

Elsayes, Khaled M., Ania Z. Kielar, Victoria Chernyak, Ali Morshid, Alessandro Furlan, William R. Masch, Robert M. Marks, et al. “LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance..” J Hepatocell Carcinoma 6 (2019): 49–69. https://doi.org/10.2147/JHC.S186239.

PMID
30788336
Full Text

DePaoli, Alex, Sudha Shankar, Mustafa R. Bashir, Bryan A. Baxter, Phung Van, Andrew Z. Yan, and Stephen Rossi. “NGM313, a Novel Once-Monthly Activator of beta-Klotho/FGFR1c, Significantly Reduces Hepatic Steatosis and Key Biomarkers of Nonalcoholic Steatohepatitis: Results of a Randomized, Active-Controlled Clamp Study in Obese Insulin Resistant Patients with NAFLD.” In Hepatology, 68:1460A-1460A. WILEY, 2018.

Scholars@Duke

Chernyak, Victoria, Kathryn J. Fowler, Aya Kamaya, Ania Z. Kielar, Khaled M. Elsayes, Mustafa R. Bashir, Yuko Kono, et al. “Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients..” Radiology 289, no. 3 (December 2018): 816–30. https://doi.org/10.1148/radiol.2018181494.

PMID
30251931
Full Text

Paredes, Angelo H., James F. Trotter, Mustafa R. Bashir, Guy W. Neff, Manal F. Abdelmalek, Grisell Ortiz-Lasanta, Mark Jaros, et al. “NGM282 Maintains a Durable Off-Treatment Response on Hepatic Steatosis, Inflammation and Fibrogenesis in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis: Results of a Multi-Center Phase 2 Dose-Finding Study.” In Hepatology, 68:1460A-1461A. WILEY, 2018.

Scholars@Duke

Pages